Mori M - Search Results

1

How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30.

Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. Fromme EK, et al. Among authors: mori m. J Clin Oncol. 2004 Sep 1;22(17):3485-90. doi: 10.1200/JCO.2004.03.025. J Clin Oncol. 2004. PMID: 15337796

2

Quality of life and pain relief during treatment with calcitriol and docetaxel in symptomatic metastatic androgen-independent prostate carcinoma.

Beer TM, Eilers KM, Garzotto M, Hsieh YC, Mori M. Beer TM, et al. Among authors: mori m. Cancer. 2004 Feb 15;100(4):758-63. doi: 10.1002/cncr.20024. Cancer. 2004. PMID: 14770432 Free article. Clinical Trial.

3

Predictors of delayed therapy after expectant management for localized prostate cancer in the era of prostate-specific antigen.

Panagiotou I, Beer TM, Hsieh YC, Mori M, Peters L, Klein T, Garzotto M. Panagiotou I, et al. Among authors: mori m. Oncology. 2004;67(3-4):194-202. doi: 10.1159/000081317. Oncology. 2004. PMID: 15557778

4

Improved detection of prostate cancer using classification and regression tree analysis.

Garzotto M, Beer TM, Hudson RG, Peters L, Hsieh YC, Barrera E, Klein T, Mori M. Garzotto M, et al. Among authors: mori m. J Clin Oncol. 2005 Jul 1;23(19):4322-9. doi: 10.1200/JCO.2005.11.136. Epub 2005 Mar 21. J Clin Oncol. 2005. PMID: 15781880

5

Effect of calcitriol on prostate-specific antigen in vitro and in humans.

Beer TM, Garzotto M, Park B, Mori M, Myrthue A, Janeba N, Sauer D, Eilers K. Beer TM, et al. Among authors: mori m. Clin Cancer Res. 2006 May 1;12(9):2812-6. doi: 10.1158/1078-0432.CCR-05-2310. Clin Cancer Res. 2006. PMID: 16675575

6

Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy.

Spurgeon SE, Hsieh YC, Rivadinera A, Beer TM, Mori M, Garzotto M. Spurgeon SE, et al. Among authors: mori m. J Urol. 2006 Mar;175(3 Pt 1):918-22. doi: 10.1016/S0022-5347(05)00353-8. J Urol. 2006. PMID: 16469580

7

Interest in physician-assisted suicide among Oregon cancer patients.

Ganzini L, Beer TM, Brouns M, Mori M, Hsieh YC. Ganzini L, et al. Among authors: mori m. J Clin Ethics. 2006 Spring;17(1):27-38. J Clin Ethics. 2006. PMID: 16689111 No abstract available.

8

Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study.

Graff JN, Mori M, Li H, Garzotto M, Penson D, Potosky AL, Beer TM. Graff JN, et al. Among authors: mori m. J Urol. 2007 Apr;177(4):1307-12. doi: 10.1016/j.juro.2006.11.054. J Urol. 2007. PMID: 17382720 Clinical Trial.

9

C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.

Beer TM, Lalani AS, Lee S, Mori M, Eilers KM, Curd JG, Henner WD, Ryan CW, Venner P, Ruether JD, Chi KN; ASCENT Investigators. Beer TM, et al. Among authors: mori m. Cancer. 2008 Jun;112(11):2377-83. doi: 10.1002/cncr.23461. Cancer. 2008. PMID: 18428198 Free article. Clinical Trial.

10

Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.

Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Schnadig ID, et al. Among authors: mori m. Cancer. 2008 Oct 15;113(8):2205-14. doi: 10.1002/cncr.23856. Cancer. 2008. PMID: 18780322 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,978 results

Search Page

Filters